These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31182761)

  • 1. Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway.
    Yang S; Zhang X; Qu H; Qu B; Yin X; Zhao H
    Cancer Gene Ther; 2020 May; 27(5):368-377. PubMed ID: 31182761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
    Yang S; Zhu Z; Zhang X; Zhang N; Yao Z
    Oncotarget; 2017 Jan; 8(4):6102-6113. PubMed ID: 28008149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gilteritinib induces PUMA-dependent apoptotic cell death via AKT/GSK-3β/NF-κB pathway in colorectal cancer cells.
    Li L; Lin L; Li M; Li W
    J Cell Mol Med; 2020 Feb; 24(3):2308-2318. PubMed ID: 31881122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.
    Chen D; Wei L; Yu J; Zhang L
    Clin Cancer Res; 2014 Jul; 20(13):3472-84. PubMed ID: 24763611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crizotinib induces PUMA-dependent apoptosis in colon cancer cells.
    Zheng X; He K; Zhang L; Yu J
    Mol Cancer Ther; 2013 May; 12(5):777-86. PubMed ID: 23427294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.
    Wang H; Zhang L; Yang X; Jin Y; Pei S; Zhang D; Zhang H; Zhou B; Zhang Y; Lin D
    Oncotarget; 2015 Jun; 6(16):14385-98. PubMed ID: 25965911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
    Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
    Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cells.
    Sun J; Knickelbein K; He K; Chen D; Dudgeon C; Shu Y; Yu J; Zhang L
    Mol Cancer Ther; 2014 May; 13(5):1298-308. PubMed ID: 24563542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
    Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
    Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer.
    Tan X; Zhang Z; Liu P; Yao H; Shen L; Tong JS
    Cell Death Dis; 2020 Dec; 11(12):1061. PubMed ID: 33311453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
    Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
    J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
    Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
    Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway.
    Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F
    Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.
    Yan J; Yang S; Tian H; Zhang Y; Zhao H
    Cell Death Dis; 2020 Nov; 11(11):943. PubMed ID: 33139695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms.
    Scott AJ; Arcaroli JJ; Bagby SM; Yahn R; Huber KM; Serkova NJ; Nguyen A; Kim J; Thorburn A; Vogel J; Quackenbush KS; Capasso A; Schreiber A; Blatchford P; Klauck PJ; Pitts TM; Eckhardt SG; Messersmith WA
    Mol Cancer Ther; 2018 Oct; 17(10):2112-2122. PubMed ID: 30026382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
    Sun J; Sun Q; Brown MF; Dudgeon C; Chandler J; Xu X; Shu Y; Zhang L; Yu J
    PLoS One; 2012; 7(8):e43158. PubMed ID: 22912816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
    Sun Q; Ming L; Thomas SM; Wang Y; Chen ZG; Ferris RL; Grandis JR; Zhang L; Yu J
    Oncogene; 2009 Jun; 28(24):2348-57. PubMed ID: 19421143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01.
    Dudgeon C; Wang P; Sun X; Peng R; Sun Q; Yu J; Zhang L
    Mol Cancer Ther; 2010 Nov; 9(11):2893-902. PubMed ID: 20978166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.